Skip to main content

Susana Miravet Delgado

Institutions of which they are part

Postdoctoral researcher
Gene Therapy at Nervous System
Vall Hebron Institut de Recerca

Susana Miravet Delgado

Institutions of which they are part

Postdoctoral researcher
Gene Therapy at Nervous System
Vall Hebron Institut de Recerca

Projects

ESTUDIO Y DESARROLLO DE LA PRIMERA PLATAFORMA TECNOLÓGICA DE ENSAYOS PARA VIRUS ADENOASOCIADOS EN TERÁPIA GÉNICA

IP: Miguel Chillon Rodriguez
Collaborators: Susana Miravet Delgado, Laia Rubio Ortega, Marina Tarrés Mercader
Funding agency: Instituto de Salud Carlos III
Funding: 296571
Reference: PMPTA22/00048
Duration: 01/01/2023 - 31/12/2024

Related news

This gene therapy protects mice against cognitive deficits associated with aging, improves motor function, and delays the onset of diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease.

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.

Related professionals

Sara Delgado Tomás

Sara Delgado Tomás

Predoctoral researcher
Cardiovascular Diseases
Read more
Lena Nerea Montaña Ernst

Lena Nerea Montaña Ernst

Research technician
Pharmacokinetic Nanoparticles
Read more
Laura Castellote Bellés

Laura Castellote Bellés

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Juan Angel Recio Conde

Juan Angel Recio Conde

Head of group
Biomedical Research in Melanoma
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.